Prescribing of antivirals for COVID-19 in a South Australian local health network according to statewide guidelines

Hiba Al Naji, Joshua M. Inglis, Emily Tucker, Debra Rowett, Rebecca Larcombe, Sophie Medlin, Arduino A. Mangoni, Tilenka Thynne

Research output: Contribution to journalArticlepeer-review


Antiviral drugs were rapidly implemented into clinical practice for the treatment of high-risk patients with COVID-19, prompting the development of statewide guidelines. This South-Australian study reviewed guideline adherence, assessed prescribing patterns and highlighted the inappropriate management of relative drug–drug interactions and dosing for renal function. Additionally, it evaluated the impact of inappropriate antiviral drug use and suggested methods to improve quality use of medicines.

Original languageEnglish
Pages (from-to)183-186
Number of pages4
JournalInternal Medicine Journal
Issue number1
Publication statusPublished - Jan 2024


  • COVID-19
  • living guidelines
  • molnupiravir
  • nirmatrelvir/ritonavir
  • prescribing
  • remdesivir

Cite this